Type of β-blocker use among patients with versus without diabetes after myocardial infarction

American Heart Journal

Volumn 168, Issue 3, 2014, Pages

  Arnold, Suzanne V ^a,b   Spertus, John A ^a,b   Lipska, Kasia J ^c   Lanfear, David E ^d   Tang, Fengming ^a   Grodzinsky, Anna ^a,b   McGuire, Darren K ^e   Gore, M Odette ^f   Goyal, Abhinav ^g   Maddox, Thomas M ^f,h   Kosiborod, Mikhail ^a,b  

^a SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HENRY FORD HOSPITAL   (United States)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^f UNIVERSITY OF COLORADO   (United States)

^g EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC BETA-ANTAGONISTS; AGED; CARBAZOLES; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PHYSICIAN'S PRACTICE PATTERNS; PROPANOLAMINES; REGISTRIES;

EID: 84908505352     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2014.04.018     Document Type: Article

References (36)